R&D News | pharmaphorum

News

BeOne nears a possible FDA okay for sonrotoclax in mantle cell lymphoma, hoping to be the second BCL-2 inhibitor in the US after AbbVie's Venclexta.

News

Kelonia only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but will report impressive results at ASH next month.

News

Novo Nordisk has decided to move its amycretin into pivotal trials in type 2 diabetes after a phase 2 readout.

News

In a boost for the UK life sciences sector, a new £800m life sciences hub located at Barts Health NHS Trust in London has been opened today.

News

GLP-1 agonists have been shown to be beneficial in a lengthening list of diseases, but it seems Alzheimer's disease may not be among them.

News

Prospects for Bayer's oral Factor XIa inhibitor asundexian have improved markedly after a phase 3 trial in secondary stroke prevention.